Assessment of potential treatments for drug-induced respiratory depression and overdose toxicity. POP: september 26, 2022 - september 25, 2023. Task order 75N95022F00003 (TO3).
Ended Awarded Last action
- Contract number
- 75N95022F00003
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $102,721
Award facts
- Opportunity
-
- Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity Pre-Solicitation · Posted Sep 7, 2021
- Contract value 100% obligated
- $102,721.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
Lovelace Biomedical Research Institute has been awarded a cost-plus-fixed-fee delivery order against the National Institutes of Health National Institute on Drug Abuse's (NIDA) Research Support Services contract vehicle to conduct an assessment of potential treatments for drug-induced respiratory depression and overdose toxicity. The one-year task order, valued at one hundred two thousand seven hundred twenty-one dollars, will support NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. No set-aside designation was applied to this award. Work will be performed in Albuquerque, New Mexico.
Quick answers
Who was awarded contract 75N95022F00003?
75N95022F00003 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2022.
How much is contract 75N95022F00003 worth?
The government has obligated $102,721 on 75N95022F00003.
Is contract 75N95022F00003 an order under another contract?
Yes. 75N95022F00003 is a delivery order under 75N95022D00019, an indefinite delivery contract.
Was contract 75N95022F00003 competed?
The extent of competition for 75N95022F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award